Global Anti-Infective Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 24-Feb-2020
No. of pages: 138

Market Overview

The global Anti-Infective Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Anti-Infective Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Anti-Infective Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anti-Infective Vaccines market has been segmented into

- Inactivated vaccines

- Conjugate vaccines

- Live/attenuated vaccines

By Application, Anti-Infective Vaccines has been segmented into:

- Bacterial diseases

- Viral diseases

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Infective Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Infective Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Infective Vaccines market.

The report offers in-depth assessment of the growth and other aspects of the Anti-Infective Vaccines market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, etc.)

- Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Anti-Infective Vaccines Market Share Analysis

Anti-Infective Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Infective Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Infective Vaccines sales, revenue and market share for each player covered in this report.

The major players covered in Anti-Infective Vaccines are:

- Emergent BioDefense Operations Lansing Inc.

- MassBiologics

- MedImmune LLC

- Sanofi Pasteur

- Intercell Biomedical

- Merck & Co.

- Organon Teknika Co.

- Diagnostics Ltd.

- Novartis Vaccines

- Barr Labs, Inc.

- Wyeth Pharmaceuticals, Inc.

- GlaxoSmithKline Biologicals

- Berna Biotech

- Protein Sciences Co.

- CSL Ltd.

- ID Biomedical Co.

Among other players domestic and global, Anti-Infective Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Anti-Infective Vaccines product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Anti-Infective Vaccines, with price, sales, revenue and global market share of Anti-Infective Vaccines in 2018 and 2019.

Chapter 3, the Anti-Infective Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anti-Infective Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Anti-Infective Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Anti-Infective Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Anti-Infective Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Anti-Infective Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Infective Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated vaccines
1.2.3 Conjugate vaccines
1.2.4 Live/attenuated vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Infective Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Bacterial diseases
1.3.3 Viral diseases
1.4 Overview of Global Anti-Infective Vaccines Market
1.4.1 Global Anti-Infective Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Emergent BioDefense Operations Lansing Inc.
2.1.1 Emergent BioDefense Operations Lansing Inc. Details
2.1.2 Emergent BioDefense Operations Lansing Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Emergent BioDefense Operations Lansing Inc. SWOT Analysis
2.1.4 Emergent BioDefense Operations Lansing Inc. Product and Services
2.1.5 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MassBiologics
2.2.1 MassBiologics Details
2.2.2 MassBiologics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MassBiologics SWOT Analysis
2.2.4 MassBiologics Product and Services
2.2.5 MassBiologics Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 MedImmune LLC
2.3.1 MedImmune LLC Details
2.3.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 MedImmune LLC SWOT Analysis
2.3.4 MedImmune LLC Product and Services
2.3.5 MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi Pasteur SWOT Analysis
2.4.4 Sanofi Pasteur Product and Services
2.4.5 Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Intercell Biomedical
2.5.1 Intercell Biomedical Details
2.5.2 Intercell Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Intercell Biomedical SWOT Analysis
2.5.4 Intercell Biomedical Product and Services
2.5.5 Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co. SWOT Analysis
2.6.4 Merck & Co. Product and Services
2.6.5 Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Organon Teknika Co.
2.7.1 Organon Teknika Co. Details
2.7.2 Organon Teknika Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Organon Teknika Co. SWOT Analysis
2.7.4 Organon Teknika Co. Product and Services
2.7.5 Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Diagnostics Ltd.
2.8.1 Diagnostics Ltd. Details
2.8.2 Diagnostics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Diagnostics Ltd. SWOT Analysis
2.8.4 Diagnostics Ltd. Product and Services
2.8.5 Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis Vaccines
2.9.1 Novartis Vaccines Details
2.9.2 Novartis Vaccines Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis Vaccines SWOT Analysis
2.9.4 Novartis Vaccines Product and Services
2.9.5 Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Barr Labs, Inc.
2.10.1 Barr Labs, Inc. Details
2.10.2 Barr Labs, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Barr Labs, Inc. SWOT Analysis
2.10.4 Barr Labs, Inc. Product and Services
2.10.5 Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wyeth Pharmaceuticals, Inc.
2.11.1 Wyeth Pharmaceuticals, Inc. Details
2.11.2 Wyeth Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wyeth Pharmaceuticals, Inc. SWOT Analysis
2.11.4 Wyeth Pharmaceuticals, Inc. Product and Services
2.11.5 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline Biologicals
2.12.1 GlaxoSmithKline Biologicals Details
2.12.2 GlaxoSmithKline Biologicals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GlaxoSmithKline Biologicals SWOT Analysis
2.12.4 GlaxoSmithKline Biologicals Product and Services
2.12.5 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Berna Biotech
2.13.1 Berna Biotech Details
2.13.2 Berna Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Berna Biotech SWOT Analysis
2.13.4 Berna Biotech Product and Services
2.13.5 Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Protein Sciences Co.
2.14.1 Protein Sciences Co. Details
2.14.2 Protein Sciences Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Protein Sciences Co. SWOT Analysis
2.14.4 Protein Sciences Co. Product and Services
2.14.5 Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 CSL Ltd.
2.15.1 CSL Ltd. Details
2.15.2 CSL Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 CSL Ltd. SWOT Analysis
2.15.4 CSL Ltd. Product and Services
2.15.5 CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 ID Biomedical Co.
2.16.1 ID Biomedical Co. Details
2.16.2 ID Biomedical Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 ID Biomedical Co. SWOT Analysis
2.16.4 ID Biomedical Co. Product and Services
2.16.5 ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-Infective Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-Infective Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Infective Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-Infective Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-Infective Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Infective Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-Infective Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-Infective Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Anti-Infective Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-Infective Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-Infective Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-Infective Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-Infective Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
6.4 France Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-Infective Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-Infective Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-Infective Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7.5 India Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-Infective Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Anti-Infective Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-Infective Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-Infective Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-Infective Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-Infective Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-Infective Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-Infective Vaccines Price by Type (2015-2020)
11 Global Anti-Infective Vaccines Market Segment by Application
11.1 Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Anti-Infective Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Anti-Infective Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-Infective Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-Infective Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-Infective Vaccines Market Forecast (2021-2025)
12.2.2 Europe Anti-Infective Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-Infective Vaccines Market Forecast (2021-2025)
12.2.4 South America Anti-Infective Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-Infective Vaccines Market Forecast (2021-2025)
12.3 Anti-Infective Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Anti-Infective Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-Infective Vaccines Market Share Forecast by Type (2021-2025)
12.4 Anti-Infective Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Anti-Infective Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-Infective Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Anti-Infective Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Infective Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Emergent BioDefense Operations Lansing Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Major Business
Table 9. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Emergent BioDefense Operations Lansing Inc. SWOT Analysis
Table 11. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services
Table 12. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 14. MassBiologics Anti-Infective Vaccines Major Business
Table 15. MassBiologics Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. MassBiologics SWOT Analysis
Table 17. MassBiologics Anti-Infective Vaccines Product and Services
Table 18. MassBiologics Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 20. MedImmune LLC Anti-Infective Vaccines Major Business
Table 21. MedImmune LLC Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. MedImmune LLC SWOT Analysis
Table 23. MedImmune LLC Anti-Infective Vaccines Product and Services
Table 24. MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Pasteur Anti-Infective Vaccines Major Business
Table 27. Sanofi Pasteur Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi Pasteur SWOT Analysis
Table 29. Sanofi Pasteur Anti-Infective Vaccines Product and Services
Table 30. Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Intercell Biomedical Basic Information, Manufacturing Base and Competitors
Table 32. Intercell Biomedical Anti-Infective Vaccines Major Business
Table 33. Intercell Biomedical Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Intercell Biomedical SWOT Analysis
Table 35. Intercell Biomedical Anti-Infective Vaccines Product and Services
Table 36. Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 38. Merck & Co. Anti-Infective Vaccines Major Business
Table 39. Merck & Co. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. Merck & Co. SWOT Analysis
Table 41. Merck & Co. Anti-Infective Vaccines Product and Services
Table 42. Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Organon Teknika Co. Basic Information, Manufacturing Base and Competitors
Table 44. Organon Teknika Co. Anti-Infective Vaccines Major Business
Table 45. Organon Teknika Co. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. Organon Teknika Co. SWOT Analysis
Table 47. Organon Teknika Co. Anti-Infective Vaccines Product and Services
Table 48. Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Diagnostics Ltd. Basic Information, Manufacturing Base and Competitors
Table 50. Diagnostics Ltd. Anti-Infective Vaccines Major Business
Table 51. Diagnostics Ltd. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 52. Diagnostics Ltd. SWOT Analysis
Table 53. Diagnostics Ltd. Anti-Infective Vaccines Product and Services
Table 54. Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis Vaccines Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Vaccines Anti-Infective Vaccines Major Business
Table 57. Novartis Vaccines Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 58. Novartis Vaccines SWOT Analysis
Table 59. Novartis Vaccines Anti-Infective Vaccines Product and Services
Table 60. Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Barr Labs, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Barr Labs, Inc. Anti-Infective Vaccines Major Business
Table 63. Barr Labs, Inc. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 64. Barr Labs, Inc. SWOT Analysis
Table 65. Barr Labs, Inc. Anti-Infective Vaccines Product and Services
Table 66. Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Wyeth Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Major Business
Table 69. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 70. Wyeth Pharmaceuticals, Inc. SWOT Analysis
Table 71. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services
Table 72. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GlaxoSmithKline Biologicals Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline Biologicals Anti-Infective Vaccines Major Business
Table 75. GlaxoSmithKline Biologicals Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 76. GlaxoSmithKline Biologicals SWOT Analysis
Table 77. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services
Table 78. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Berna Biotech Basic Information, Manufacturing Base and Competitors
Table 80. Berna Biotech Anti-Infective Vaccines Major Business
Table 81. Berna Biotech Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 82. Berna Biotech SWOT Analysis
Table 83. Berna Biotech Anti-Infective Vaccines Product and Services
Table 84. Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Protein Sciences Co. Basic Information, Manufacturing Base and Competitors
Table 86. Protein Sciences Co. Anti-Infective Vaccines Major Business
Table 87. Protein Sciences Co. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 88. Protein Sciences Co. SWOT Analysis
Table 89. Protein Sciences Co. Anti-Infective Vaccines Product and Services
Table 90. Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. CSL Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. CSL Ltd. Anti-Infective Vaccines Major Business
Table 93. CSL Ltd. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 94. CSL Ltd. SWOT Analysis
Table 95. CSL Ltd. Anti-Infective Vaccines Product and Services
Table 96. CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. ID Biomedical Co. Basic Information, Manufacturing Base and Competitors
Table 98. ID Biomedical Co. Anti-Infective Vaccines Major Business
Table 99. ID Biomedical Co. Anti-Infective Vaccines Total Revenue (USD Million) (2017-2018)
Table 100. ID Biomedical Co. SWOT Analysis
Table 101. ID Biomedical Co. Anti-Infective Vaccines Product and Services
Table 102. ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Anti-Infective Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 104. Global Anti-Infective Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global Anti-Infective Vaccines Sales by Regions (2015-2020) (K Units)
Table 106. Global Anti-Infective Vaccines Sales Market Share by Regions (2015-2020)
Table 107. Global Anti-Infective Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 108. North America Anti-Infective Vaccines Sales by Countries (2015-2020) (K Units)
Table 109. North America Anti-Infective Vaccines Sales Market Share by Countries (2015-2020)
Table 110. North America Anti-Infective Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020)
Table 112. Europe Anti-Infective Vaccines Sales by Countries (2015-2020) (K Units)
Table 113. Europe Anti-Infective Vaccines Sales Market Share by Countries (2015-2020)
Table 114. Europe Anti-Infective Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific Anti-Infective Vaccines Sales by Regions (2015-2020) (K Units)
Table 116. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific Anti-Infective Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 118. South America Anti-Infective Vaccines Sales by Countries (2015-2020) (K Units)
Table 119. South America Anti-Infective Vaccines Sales Market Share by Countries (2015-2020)
Table 120. South America Anti-Infective Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 121. South America Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa Anti-Infective Vaccines Sales by Countries (2015-2020) (K Units)
Table 123. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Anti-Infective Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020)
Table 126. Global Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 127. Global Anti-Infective Vaccines Sales Share by Type (2015-2020)
Table 128. Global Anti-Infective Vaccines Revenue by Type (2015-2020) (USD Million)
Table 129. Global Anti-Infective Vaccines Revenue Share by Type (2015-2020)
Table 130. Global Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 131. Global Anti-Infective Vaccines Sales Share by Application (2015-2020)
Table 132. Global Anti-Infective Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 133. Global Anti-Infective Vaccines Market Share Forecast by Regions (2021-2025)
Table 134. Global Anti-Infective Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 135. Global Anti-Infective Vaccines Market Share Forecast by Type (2021-2025)
Table 136. Global Anti-Infective Vaccines Sales Forecast by Application (2021-2025)
Table 137. Global Anti-Infective Vaccines Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Anti-Infective Vaccines Picture
Figure 2. Global Sales Market Share of Anti-Infective Vaccines by Type in 2019
Figure 3. Inactivated vaccines Picture
Figure 4. Conjugate vaccines Picture
Figure 5. Live/attenuated vaccines Picture
Figure 6. Anti-Infective Vaccines Sales Market Share by Application in 2018
Figure 7. Bacterial diseases Picture
Figure 8. Viral diseases Picture
Figure 9. Global Anti-Infective Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Anti-Infective Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Anti-Infective Vaccines Sales Market Share by Manufacturer in 2019
Figure 30. Global Anti-Infective Vaccines Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Anti-Infective Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Anti-Infective Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Anti-Infective Vaccines Revenue Market Share by Regions (2015-2020)
Figure 37. Global Anti-Infective Vaccines Revenue Market Share by Regions in 2018
Figure 38. North America Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
Figure 39. Europe Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
Figure 41. South America Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Anti-Infective Vaccines Sales and Growth Rate (2015-2020)
Figure 43. North America Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Anti-Infective Vaccines Sales Market Share by Countries (2015-2020)
Figure 45. North America Anti-Infective Vaccines Sales Market Share by Countries in 2018
Figure 46. North America Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Anti-Infective Vaccines Revenue Market Share by Countries in 2018
Figure 48. United States Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Anti-Infective Vaccines Revenue Market Share by Countries in 2019
Figure 54. Germany Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Anti-Infective Vaccines Revenue Market Share by Regions 2019
Figure 62. China Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Anti-Infective Vaccines Sales Market Share by Countries in 2019
Figure 69. South America Anti-Infective Vaccines Revenue Market Share by Countries in 2019
Figure 70. Brazil Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Anti-Infective Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Anti-Infective Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Anti-Infective Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Anti-Infective Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Anti-Infective Vaccines Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Anti-Infective Vaccines Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Anti-Infective Vaccines Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Anti-Infective Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Anti-Infective Vaccines Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs